Related Experiment Video
Updated: May 3, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Pediatric chloral hydrate poisonings and death following outpatient procedural sedation
Sean Patrick Nordt1, Cyrus Rangan, Madhu Hardmaslani
1Department of Emergency Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA, spnordt@gmail.com.
Insights
Chloral hydrate, a sedative hypnotic, poses significant risks in pediatric procedural sedation, including poisoning and death. Safer alternatives with better safety profiles should be prioritized for children.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Toxicology
- Pharmacology
Background:
- Chloral hydrate has a long history of use as a sedative hypnotic, particularly for procedural sedation in children.
- Despite its historical use, safer and more effective alternatives are now available for pediatric sedation.
Observation:
- Three cases of pediatric chloral hydrate poisoning are presented, all occurring after procedural sedation in outpatient settings.
- Patients, aged 15 months to 4 years, required resuscitation, with one fatality.
- Poisoning incidents occurred in outpatient clinic settings, highlighting potential risks outside of supervised hospital environments.
Findings:
- Chloral hydrate is associated with severe adverse effects, including toxicity and mortality in pediatric patients.
- The drug's pharmacokinetic and safety profiles are less predictable compared to alternative sedative agents.
- Procedural sedation with chloral hydrate in outpatient settings carries inherent risks due to potential for overdose and lack of immediate advanced care.
Implications:
- There is a critical need to identify and utilize safer sedative agents for pediatric procedural sedation.
- Healthcare providers should transition away from chloral hydrate due to its adverse event profile.
- Procedural sedation in children should only be administered in settings with continuous cardiorespiratory monitoring and immediate access to resuscitation resources.
Introduction:
Chloral hydrate has been used medicinally since the 1800 s as a sedative hypnotic, most commonly for procedural sedation. As it is administered orally and available in a liquid formulation, it is used almost exclusively in pediatric patients despite many safer and more effective alternative agents being available.
Case Series:
We present three cases of pediatric chloral hydrate poisoning, all occurring following procedural sedation in outpatient clinic settings and presenting to the emergency department. The ages ranged from 15 months to 4 years of age and all required resuscitation. Unfortunately, the 4-year-old died.
Conclusion:
Choral hydrate is associated with significant adverse effects, including death, and safer alternatives for pediatric procedural sedation should be sought and utilized. There are a number of more effective sedative agents with more predictable pharmacokinetic and safety profiles than chloral hydrate including parenteral and oral agents. The practice of pre-procedure sedation should be performed only in a supervised setting where cardiorespiratory monitoring can occur in all cases.
Related Concept Videos
Parenteral Anesthetics: Overview
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Stages of General Anesthesia
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Prevention of Further Absorption of Poison

